NCT04878861 is a NA clinical trial of Training in the blind field in Hemianopia, sponsored by University of Oxford.

Who is sponsoring NCT04878861?

NCT04878861 is sponsored by University of Oxford.

What drugs are being tested in NCT04878861?

Interventions in NCT04878861: Training in the blind field.

What condition does NCT04878861 study?

NCT04878861 studies Hemianopia, Hemianopsia, Quadrantanopia, Stroke Induced Vision Loss.

Is NCT04878861 still recruiting?

NCT04878861 is currently status unknown. Last updated 10 May 2021.

Last reviewed 2021-05-10 · How we verify

NCT04878861

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Rehabilitating Visual Deficits Caused by Stroke

Status unknown NA Last updated 10 May 2021

What this trial tests

NA trial testing Training in the blind field in Hemianopia in 20 participants. Status unknown.

Timeline

13 December 2020

Primary endpoint
16 October 2024

16 October 2024

Quick facts

Lead sponsor	University of Oxford
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	13 December 2020
Primary completion	16 October 2024
Estimated completion	16 October 2024
Sites	1 location across United Kingdom

Drugs / interventions tested

Training in the blind field

Conditions studied

Hemianopia — all drugs for Hemianopia →
Hemianopsia — all drugs for Hemianopsia →
Quadrantanopia — all drugs for Quadrantanopia →
Stroke Induced Vision Loss — all drugs for Stroke Induced Vision Loss →

Sponsor

University of Oxford

Who can join

Adults 18 to 80, any sex, with Hemianopia or Hemianopsia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research aims to understand the efficacy of a visual training task to improve visual loss after stroke, also known as hemianopia. The investigators aim to understand whether training can improve vision and which areas or pathways in the brain are responsible for this improvement.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Rehabilitating homonymous visual field deficits: white matter markers of recovery-stage 2 registered report.
Willis HE, Caron B, Cavanaugh MR, Starling L, et al · · 2024 · cited 6× · PMID 39429244 · DOI 10.1093/braincomms/fcae323
Persistence of training-induced visual improvements after occipital stroke
Willis HE, Farenthold B, Millington-Truby RS, Willis R, et al · · 2024 · DOI 10.1101/2024.10.24.24316036

Verify or expand the search:

Other trials of Training in the blind field

Trials testing the same drug.

NCT03350919 — Visual Restoration for Hemianopia · NA · completed

Other recruiting trials for Hemianopia

Currently open trials in the same condition.

NCT07134777 — Mechanisms of Visual Restoration After Occipital Stroke · recruiting
NCT07105358 — Visual Plasticity Following Brain Lesions · NA · recruiting
NCT06995313 — Biofeedback Training for Hemianopia · NA · recruiting
NCT03475173 — New Non-invasive Modalities for Assessing Retinal Structure and Function · NA · recruiting

Other University of Oxford trials

Trials by the same sponsor.

NCT05380388 — A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 ) · Phase 2 · not yet recruiting
NCT07470424 — A Clinical Study of Piperaquine, Pyronaridine, and Artesunate Administered in Combination in Healthy Adults · Phase 1 · not yet recruiting
NCT07345910 — Environment, Pathogens, and Host Interactions in Melioidosis · not yet recruiting
NCT07434973 — Stratification and Treatment in Early Psychosis Study - PROMOTE · Phase 3 · not yet recruiting
NCT07460401 — 'Do Patient Characteristics Associate With Poor Outcome With Femoral Acetabular Impingement Syndrome (FAIS) Following Ph · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04878861 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Oxford
Last refreshed: 10 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04878861.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing